Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy3 maleimide non sulfonated 25mg'

Search results for: 'cy3 maleimide non sulfonated 25mg'

Items 71-80 of 139

Page
per page
  1. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
  2. AG-18
    A1173 AG-18
    Summary: EGFR/PDGFR inhibitor
  3. PQ 401
    A2033 PQ 401
     1 Citation
    Summary: IGF1R inhibitor,potent and cell-permeable
      insoluble in H2O; ≥17.1 mg/mL
  4. DMH-1
    B3686 DMH-1
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  5. JNJ-38877605
    A5092 JNJ-38877605
    Summary: C-Met inhibitor,ATP-competitive
      insoluble in H2O; ≥18.85 mg/mL
  6. AMG-208
    A1186 AMG-208
    Summary: C-Met inhibitor,potent and highly selective
      insoluble in EtOH; insoluble in H2O; ≥3.83 mg/mL
  7. HA-100 (hydrochloride)
    C4953 HA-100 (hydrochloride)
    Summary: inhibitor of protein kinases (PKs)
      insoluble in EtOH; ≥131.8 mg/mL
  8. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  9. SU 5402
    A3843 SU 5402
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR2/FGFR/PDGFR/EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.8 mg/mL
  10. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL

Items 71-80 of 139

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 8item
  2. Axl 3item
  3. ALK 8item
  4. Broad Spectrum Protein Kinase Inhibitor 2item
  5. c-Kit 3item
  6. c-MET 13item
  7. CSF-1R 1 item
  8. EGFR 26item
  9. FAK 4item
  10. FGFR 7item
  11. FLT3 7item
  12. HER2 6item
  13. IGF1R 5item
  14. Insulin Receptor 1 item
  15. LRRK2 4item
  16. PDGFR 9item
  17. PTKs/RTKs 1 item
  18. Pyk2 2item
  19. ROR 4item
  20. Spleen Tyrosine Kinase (Syk) 6item
  21. Src 9item
  22. Tie-2 2item
  23. Trk 3item
  24. VEGFR 26item
Specificity
  1. Selective 55item
Reversibility
  1. Reversible 6item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 1 item
  3. CSF-1R 3item
  4. MER 1 item
  5. FLT3 6item
  6. VEGFR 18item
  7. PDGFR 13item
  8. c-Kit 4item
  9. RET 1 item
  10. Bcr-Abl 6item
  11. FGFR 10item
  12. MET 4item
  13. Src 8item
  14. Trk Receptors 3item
  15. STAT 1 item
  16. EGFR 11item
  17. FAK 3item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 2item
  20. Syk 4item
  21. ErbB 2item
  22. c-MET 5item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 2item
  26. Pyk2 3item
  27. LRRK2 3item
  28. Insulin and Insulin-like Receptors 1 item
  29. ALK 3item
  30. ROS1 2item
  31. Angiotensin-Converting Enzymes (ACEs) 1 item
  32. Tie-2 2item
  33. c-Fyn 1 item
  34. 5-Lipoxygenases 1 item
  35. Insulin Receptors 1 item
  36. IRG-1R 1 item
  37. ZAP-70 1 item
  38. TAM kinase 1 item
  39. insulin 1 item
  40. PTK 1 item
  41. Flk1 1 item
  42. YES 1 item
  43. Fyn 1 item
  44. enoyl-acyl-carrier protein reductase 1 item
  45. tropomyosin receptor kinase 1 item
  46. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 66item
  2. Cell Experiments 44item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 1 item
  6. Breast Cancer 11item
  7. Cancer 49item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 2item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Glioblastoma 1 item
  14. Glioma 3item
  15. Hepatocellular Carcinoma 3item
  16. Leukemia 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 3item
  19. Lymphoma 1 item
  20. Multiple Myeloma 3item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 4item
  24. Pancreatic Cancer 7item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 2item
  29. Thyroid Cancer 1 item